Long-term Risk of Cardiovascular Events With Rosiglitazone. A Meta-analysis.
Sonal Singh, MD; Yoon K. Loke, MBBS, MD; Curt D. Furberg, MD, PhD
This paper can be accessed at: http://jama.ama-assn.org/cgi/content/full/298/10/1189
The study showed that people with diabetes who took rosiglitazone
(Avandia) were 42% more likely to have a heart attack than those who didn’t take the drug, and were twice as likely to develop heart failure.AMAZON UK Before You Take That Pill: Why the Drug Industry May Be Bad for Your Health
AMAZON USA Before You Take that Pill: Why the Drug Industry May Be Bad for Your Health
ADVERT: Click here for The Original Diabetes Reversal Report. Written And Researched By An Ex-diabetic.
Click here to find out how to get the FREE shopping APP that finds you the cheapest prices for all your shopping
